-
1
المؤلفون: Hagen, P. van, Hulshof, M.C.C., Lanschot, J.J. van, Steyerberg, E.W., Berge Henegouwen, M.I. van, Wijnhoven, B.P., Richel, D.J., Nieuwenhuijzen, G.A., Hospers, G.A., Bonenkamp, J.J., Cuesta, M.A., Blaisse, R.J., Busch, O.R., Kate, F.J. ten, Creemers, G.J., Punt, C.J.A., Plukker, J.T., Verheul, H.M., Spillenaar Bilgen, E.J., Dekken, H. van, Sangen, M.J. van der, Rozema, T., Biermann, K., Beukema, J.C., Piet, A.H., Rij, C.M. van, Reinders, J.G., Tilanus, H.W., Gaast, A. van der, Krieken, J.H. van
المساهمون: CCA -Cancer Center Amsterdam, Radiotherapy, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Surgery, Oncology, Other departments, Gastroenterology and Hepatology, Pathology, Medical oncology, Radiation Oncology, CCA - Innovative therapy, Public Health, Medical Oncology, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON)
المصدر: New England journal of medicine, 366(22), 2074-2084. Massachussetts Medical Society
The New England Journal of Medicine, 366, 2074-84
van Hagen, P, Hulshof, M C C M, van Lanschot, J J B, Steyerberg, E W, Henegouwen, M I V, Wijnhoven, B P L, Richel, D J, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R C, Ten Kate, F J W, Creemers, G J, Punt, C J A, Plukker, J T M, Verheul, H M W, Bilgen, E J S, van Dekken, H, van der Sangen, M J C, Rozema, T, Biermann, K, Beukema, J C, Piet, A H M, van Rij, C, Reinders, J G, Tilanus, H W & van der Gaast, A 2012, ' Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer ', New England Journal of Medicine, vol. 366, no. 22, pp. 2074-2084 . https://doi.org/10.1056/NEJMoa1112088
The New England Journal of Medicine, 366, 22, pp. 2074-84
New England Journal of Medicine, 366(22), 2074-2084. Massachussetts Medical Society
New England Journal of Medicine, 366(22), 2074-2084. MASSACHUSETTS MEDICAL SOCمصطلحات موضوعية: Male, Esophageal Neoplasms, SURGERY, medicine.medical_treatment, Kaplan-Meier Estimate, Carboplatin, CHEMORADIATION, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant therapy, Immune Regulation Translational research [NCMLS 2], Hazard ratio, PHASE-III TRIAL, General Medicine, Middle Aged, Translational research Tissue engineering and pathology [ONCOL 3], Neoadjuvant Therapy, SURVIVAL, Adenocarcinoma, Female, Esophagogastric Junction, RADIOTHERAPY, Adult, medicine.medical_specialty, CARCINOMA, Paclitaxel, Preoperative care, Quality of Care [ONCOL 4], Invasive mycoses and compromised host [N4i 2], CISPLATIN, SDG 3 - Good Health and Well-being, Translational research [ONCOL 3], Preoperative Care, medicine, Carcinoma, Humans, Aged, business.industry, PERIOPERATIVE CHEMOTHERAPY, ADENOCARCINOMA, Chemoradiotherapy, Adjuvant, medicine.disease, Surgery, Regimen, chemistry, WEEKLY PACLITAXEL, business, Chemoradiotherapy, Follow-Up Studies
وصف الملف: application/pdf
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.